LBRX
LB Pharmaceuticals Inc Common StockNASDAQHealthcare$25.69+3.55%ClosedMarket Cap: $649.9M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
2.26
P/S
0.00
EV/EBITDA
-15.71
DCF Value
$9.67
FCF Yield
-5.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-19.5%
ROA
-8.1%
ROIC
-9.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $0.00 | $-11.5M | $-0.45 |
| FY 2025 | $0.00 | $-25.2M | $-1.00 |
| Q3 2025 | $0.00 | $-3.6M | $-0.14 |
| Q2 2025 | $0.00 | $-5.1M | $-20.21 |
Analyst Ratings
View AllStifelBuy
2026-03-27StifelBuy
2025-12-11